As part of our ‘Spotlight On’ series, we focus on Axol Bioscience, a company who provides human cell culture systems for medical research, disease modelling and drug development. Axol Bioscience supplies high quality human cells, both healthy and diseased, to many of the world’s biggest pharmaceutical companies and best known research institutions. Axol generates stem … Continued
[iframe id=”https://www.youtube.com/embed/QMRcLvn1-mo” align=”left” mode=”normal” autoplay=”yes” parameters=”https://youtu.be/QMRcLvn1-mo”] Scancell, the developer of novel immunotherapies for the treatment of cancer, today announces that it has raised £3.9m at a price of 5 pence per share from Vulpes Life Sciences Fund (“Vulpes”) under existing shareholder authorities. Vulpes Investment Management was founded in 2011 by Stephen and Martin Diggle and … Continued
Money management app Money Dashboard has released integrations with three new account providers – Revolut, Chip and Marcus by Goldman Sachs. The integrations help consumers track spending and progress towards their savings goals in real time. Money Dashboard is the first UK personal finance app to release an integration with Revolut and follows the recent integration … Continued
Calculus Capital and Stargrove Pictures launch ‘new breed’ creative content fund, in association with BFI UK Creative Content EIS Fund, will deliver vital equity finance to UK screen content companies Designed to exploit the global surge in demand for premium content largely fuelled by the rapid growth of subscription services such as Netflix and Amazon … Continued
Lonza chooses Synpromics’ novel inducible promoter platform to manufacture biopharmaceuticals Edinburgh, UK, 16th May 2019 / Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for the commercialisation of a number of inducible promoters to improve the manufacturing of biopharmaceuticals. The commercial agreement with Lonza follows the award of an Innovate UK grant to Synpromics announced on 23 … Continued
Cambridge, UK., 3rd May 2019: Arecor, today announces that it has signed a collaboration with a new major global pharmaceutical partner. Under the collaboration, Arecor will leverage its ArestatTM technology to develop superior liquid formulations of its partner’s proprietary products. The partner will fund the development work and has the option to acquire the rights to the formulation and … Continued
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, announced it has completed the development of a next generation ultra-sensitive lateral flow-based technology platform. Initially being exemplified through the development of low cost, high performance devices for malaria and HIV, the novel diagnostics can be visually read and demonstrate … Continued
Former Revolut chief financial officer Peter O’Higgins is taking up the same title as he leads Money Dashboard’s finance and operations function as it moves on to the next stage of growth. Money Dashboard CEO Steve Tigar said: “Peter was part of Revolut’s top team and saw the business grow from 200,000 to over 4.5 … Continued
ARECOR SIGNS A NEW MULTI-PRODUCT COLLABORATION WITH A MAJOR GLOBAL PHARMACEUTICAL COMPANY Cambridge, UK, 3rd May 2019: Arecor Limited (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology, ArestatTM to develop superior treatments for a range of disease areas, including diabetes, today announces that it has signed a collaboration … Continued
Calculus are delighted to announce a 2.5m investment in Wazoku. Wazoku’s main product is Idea Spotlight, an idea management platform used by enterprise clients including the UK Ministry of Defence, John Lewis & Partners, HSBC, and Aviva. The goal of the platform is to capture, evaluate, improve and implement ideas from across any audience, whether … Continued